Sep 1, 2026 Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
Jun 25, 2026 Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets
Jun 4, 2026 Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
May 4, 2026 Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference
Apr 16, 2026 Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
